Before GLP-1s won over insurers and consumers alike, a whole generation of obesity drugs failed to reach blockbuster status; some instead went to bankruptcy court.
—
Avalon Pernell,
Fortune,
29 Aug. 2026
For The Washington Post via Getty Images As use of GLP-1s have increased in the United States, some companies have dropped coverage of the drugs for their employees.
Examples are automatically compiled from online sources to
show current usage.Read More
Opinions expressed in the examples do not represent those of Merriam-Webster or its editors.
Send us feedback.